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respect to low ICR. Studies assessing iodine status in a popu-
lation should take into account that an individual with a low 
UI excretion in one measurement is not necessarily perma-
nently iodine deficient. On the other hand, current high ICR 
could have been predicted by high ICR 5 years ago. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Urinary iodine (UI) excretion is used to determine the 
state of iodine supply in populations. Large intra-individ-
ual variations in UI excretion concentrations arise main-
ly from variable iodine ingestion. Most ingested iodine is 
excreted on the day of ingestion  [1] , with a peak at 4–5 h 
after a main meal  [2] . Some sources of nutrition, such as 
sea fish  [3] and milk  [4, 5] , include a large amount of io-
dine. So far, few studies have investigated intra-individu-
al variations in UI excretion  [1, 2, 6–9] , with the result 
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 Abstract 
 Background: It has not been investigated whether there
are associations between urinary iodine (UI) excretion mea-
surements some years apart, nor whether such an associa-
tion remains after adjustment for nutritional habits. The aim 
of the present study was to investigate the relation between 
iodine-creatinine ratio (ICR) at two measuring points 5 years 
apart.  Methods: Data from 2,659 individuals from the Study 
of Health in Pomerania were analyzed. Analysis of covariance 
and Poisson regressions were used to associate baseline with 
follow-up ICR.  Results: Baseline ICR was associated with fol-
low-up ICR. Particularly, baseline ICR  1 300   g/g was related 
to an ICR  1 300   g/g at follow-up (relative risk, RR: 2.20; p  ! 
0.001). The association was stronger in males (RR: 2.64; p  ! 
0.001) than in females (RR: 1.64; p = 0.007). In contrast, base-
line ICR  ! 100   g/g was only associated with an ICR  ! 100 
  g/g at follow-up in males when considering unadjusted 
ICR.  Conclusions: We detected only a weak correlation with 
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that a single non-fasting spot urine sample gives only 
rough information on a subject’s iodine status, with even 
several samples being insufficient. All of these studies  [1, 
2, 6–9] were conducted with less than 200 participants 
and focused on day-to-day variations in iodine concen-
trations.
 According to the World Health Organization, iodine 
deficiency is defined as a UI excretion below 100   g/l  [10] . 
To assess the iodine status in populations, this criteria is 
widely used. However, it is difficult to categorize an indi-
vidual as permanently iodine deficient based on only one 
UI measurement since the intra-individual variation in 
UI excretion levels is large. Consequently, the number of 
permanent iodine deficient individuals might be overes-
timated in these studies.
 Thus, the aim of the present study was to investigate 
the relation between unadjusted as well as adjusted io-
dine-creatinine ratio (ICR) at two measuring points 5 
years apart in a large population-based study. Nutrition-
al habits were considered in all calculations.
 Design and Methods 
 Study Subjects 
 The Study of Health in Pomerania (SHIP) is a population-
based cohort study in West Pomerania, a region in the northeast 
of Germany containing the three cities Greifswald, Stralsund and 
Anklam, and 29 surrounding communities  [11] . Like most parts 
of Germany, West Pomerania is a region of former iodine defi-
ciency  [12] . During the last 15 years, iodine supply has been nor-
malized due to an effective iodine fortification program.
 The total population comprised 212,157 inhabitants. For base-
line examinations, a sample from the population aged 20–79 years 
was drawn from population registries, in which every German 
resident is listed. The net sample (without migrated or deceased 
persons) comprised 6,267 eligible subjects. SHIP finally included 
4,310 participants (2,117 men and 2,193 women) corresponding 
to a response of 68.8%  [11] . Baseline examinations were conduct-
ed between 1997 and 2001. Between 2002 and 2006, all partici-
pants were re-invited to take part in a 5-year examination follow-
up, of which 3,300 subjects took part (1,589 men and 1,711 women; 
83.5% of all eligible subjects). The median follow-up time was 5.0 
years (minimum, 4.4 years; maximum, 8.6 years; 17,314.5 person-
years). All participants gave informed written consent. The study 
followed the recommendations of the Declaration of Helsinki
and was approved by the Ethics Committee of the University of 
Greifswald.
 Of the 3,300 individuals who participated at baseline and fol-
low-up, 162 subjects (90 women) had missing data in one of the 
considered variables, a further 459 subjects (350 women) received 
thyroid medication, and 20 subjects (6 women) had renal failure. 
These 641 individuals (446 women) were excluded from further 
analysis, which resulted in a study population of 2,659 partici-
pants (1,265 women).
 Assessments 
 Sociodemographic characteristics and medical histories on 
thyroid disorders were assessed by computer-aided personal in-
terviews. Education was categorized into two levels (low,  ^  10 
years; high,  1 10 years). Ingestion of fish, milk and eggs were se-
lected from a food-frequency questionnaire  [13] . For each nutri-
ent, participants were defined as regular consumers if the nutrient 
was ingested at least once during the last week. Renal failure was 
defined by a glomerular filtration rate  ! 30 ml/min/1.73 m 2 , 
which was estimated by the simplified Modification of Diet in 
Renal Disease formula eGFR = 186  ! serum creatinine –1.154   ! 
age –0.203  [ ! 0.742 if female]. Weight was measured to the nearest 
0.1 kg in light clothing and without shoes using standard digital 
scales (Soehnle-Waagen GmbH, Nassau, Germany). Thyroid ul-
trasonography was performed in both examinations using an Ul-
trasound VST-Gateway with a 5-MHz linear array transducer 
(Diasonics, Santa Clara, Calif., USA). Thyroid volume was calcu-
lated as length  ! width  ! depth  ! 0.479 (ml) for each lobe  [14] . 
Goiter was defined as a thyroid volume of  1 18 ml in women and 
 1 5 ml in men  [15] .
 Spot urine samples were collected between 07.00 a.m. and 04.00 
p.m. and analyzed for iodine concentration by a photometric pro-
cedure (Photometer ECOM 6122; Eppendorf, Hamburg, Germany) 
with Sandell and Kolthoff reaction  [16] . Urinary creatinine was an-
alyzed on the basis of the Jaffé reaction  [17] , and ICR was calcu-
lated. During the course of the study, the inter-assay coefficient of 
variation for iodine was 4.18%. Additionally, we computed age- and 
sex-adjusted ICR using the following formula: iodine (  g/l)/[cre-
atinine (g/l)/expected creatinine excretion (g/day)]. Expected cre-
atinine 24-hour excretion values were calculated according to a 
Belgian population-based study  [18, 19] . The expected 24-hour
creatinine excretion for men declined from 1.74 g (25–49 years) 
through 1.63 g (50–59 years) and 1.47 g (60–69 years) to 1.39 g ( 6 70 
years). For women, values were 1.23 g (25–49 years), 1.15 g (50–59 
years), 1.07 g (60–69 years) and 1.00 g ( 6 70 years). Participants 
were segmented into three groups according to ICR at baseline (cut-
offs: 100 and 300   g/g). Spot urine samples were classified into four 
categories based on the time of collecting: before 12 a.m. at baseline 
and follow-up, after 12.00 a.m. at baseline and follow-up, before 
12.00 a.m. at baseline and after 12.00 a.m. at follow-up, and after 
12.00 a.m. at baseline and before 12.00 a.m. at follow-up.
 Statistical Analyses 
 Data on quantitative characteristics are expressed as medi-
ans and interquartile ranges (IQR). Data on qualitative charac-
teristics are expressed as percent values or absolute numbers as 
indicated. Comparisons between groups were made using Chi-
squared test (qualitative data) or Wilcoxon test (quantitative 
data). Wilcoxon’s signed-rank test was used for paired data. ICR 
concentrations at baseline were associated with ICR concentra-
tions at follow-up by linear and Poisson regression models  [20] . 
All models were adjusted for age, sex, weight, time of urine sam-
pling, time between baseline and follow-up, and ingestion of 
fish, eggs and milk. The same adjustments were used for analyz-
ing the association of baseline ICR with incident goiter. For this 
analysis, a further 19 participants with history of thyroid sur-
gery between baseline and follow-up were excluded. A value of 
p  ! 0.05 was considered statistically significant. To assess the 
sensitivity of our results to nonresponse and dropout, we applied 
statistical weights. The aim of this approach was to give more 
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weight to subjects whose propensity to drop out of the study was 
high. The weights accounted for nonresponse to baseline (SHIP-
0) and for dropout to follow-up (SHIP-1) based on sociodemo-
graphic and health-related variables. Robust standard errors 
were computed for all weighted analyses. All statistical analyses 
were performed with SAS 9.1 (SAS Institute, Inc., Cary, N.C., 
USA). This paper was written in accordance with the STROBE 
statement, giving guidelines for reporting observational studies 
 [21] .
 Results 
 UI concentrations ( fig. 1 a) and ICR ( fig. 1 b) at baseline 
and follow-up are presented. Median UI concentrations 
decreased from 125   g/l (IQR: 76.4–180.0   g/l) at base-
line to 111   g/l (IQR: 64.3–173.0   g/l) at follow-up (p  ! 
0.001), and median ICR decreased from 134.2   g/g (IQR: 
100.3–179.6   g/g) to 130.4   g/g (IQR: 92.2–179.0   g/g) 
(p = 0.002). Consequently, there were fewer participants 
with a UI concentration of  ! 100   g/l or an ICR of  ! 100 
  g/g at baseline than at follow-up ( table 1 ), but no differ-
ences between baseline and follow-up for a UI concentra-
tion  1 300   g/l or an ICR  1 300   g/g. Of those partici-
pants who had an ICR  ! 100   g/g at baseline, 42.0% 
maintained  ! 100   g/g at follow-up. Of those participants 
who had an ICR  1 300   g/g at baseline, 19.0% maintained 
 1 300   g/g at follow-up.  Table 1 shows the characteristics 
of the study population stratified by sex. UI concentra-
tions were higher in males than in females, whereas ICR 
was lower in males than in females, and adjusted ICR was 
comparable between the sexes.
 Multivariable Poisson regression analyses revealed a 
significant association between an ICR  ^  100   g/g at 
baseline and an ICR  ^  100   g/g at follow-up in the whole 
population ( table 2 ). This association was only present in 
males, but not in females. An ICR  1 300   g/g at baseline 
was significantly associated with an ICR  1 300   g/g at 
follow-up. This association was present in both sexes.
 Adjusted ICR  ^  100   g/g was not associated with an 
adjusted ICR  ^  100   g/g at follow-up ( table 3 ). Also strat-
ification by sex showed no significant effects. Adjusted 
ICR  1 300   g/g at baseline was significantly associated 
with an ICR  1 300   g/g at follow-up. This association was 
present in both sexes, and was stronger in males than in 
females.
 There were no significant associations between base-
line unadjusted ICR and incident goiter in multivariable 
analysis for both sexes. In males, baseline-adjusted ICR 
 1 300   g/day was significantly associated with incident 
goiter (RR: 1.53; 95% CI: 1.10–2.13; p value = 0.011).
 Discussion 
 In the present study, we investigated the interdepen-
dency of two UI measurements 5 years apart. We detect-
ed a correlation between these measurements. In particu-
lar, the risk of having a high UI excretion  1 300   g/g at 
0
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 Fig. 1. UI concentrations ( a ) and ICR ( b ) at baseline and follow-up. 
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follow-up was five times higher for males with a high UI 
excretion  1 300   g/g at baseline compared to males with 
a UI excretion in the interval of 100–300   g/g at baseline. 
In women, these associations were less strong, but the risk 
of having a high UI excretion  1 300   g/g at follow-up was 
still two times higher for women with a high UI excretion 
 1 300   g/g at baseline compared to females with a UI ex-
cretion in the interval of 100–300   g/g at baseline. A cor-
relation between UI excretion  ^  100   g/g between base-
line and follow-up was detected only for unadjusted but 
not for adjusted ICR.
 UI excretion is commonly used as a marker of iodine 
supply status in population studies  [10] . With respect to 
low ICR ( ! 100   g/g), baseline ICR was only correlated 
with follow-up ICR in males when using unadjusted ICR. 
No correlation was detected for adjusted ICR. Our results 
suggest that participants who had a UI excretion of  ! 100 
  g/g at baseline do not necessarily remain iodine defi-
cient. Only a proportion of 42% of all participants had a 
low UI excretion at both measurements. This strongly in-
dicates that cross-sectional studies to determine the io-
dine status in a population overestimate the proportion 
of iodine-deficient subjects.
 In participants with a high ICR ( 1 300   g/g), the pre-
dictivity of ICR was better in males than in females. Be-
sides nutritional factors, which might possibly explain 
these findings, several hypotheses might be generated 
from this finding. The UI excretion depends on the nu-
tritional iodine intake, the iodine uptake into the thyroid 
gland and the perfusion of the kidney  [22] . Individual 
setup of renal reabsorption may determine a loss of io-
dine  [23, 24] and might be inhibited, e.g. by chronic renal 
insufficiency  [25] . Also genetic variants may influence io-
dine metabolism and excretion  [26] . Particularly, it has 
been previously reported that renal iodine re-uptake 
might be influenced by the renal sodium iodide symport-
er  [27] , which also transfers iodine into the thyroid cells. 
Inhibition of this mechanism might lead, hypothetically, 






Iodine, g/l 137.0 (93.3–187.0) 109.0 (63.2–170.0)
ICR, g/g 120.1 (91.6–158.5) 154.0 (114.2–202.6)
Adjusted ICR, g/day 192.8 (149.0–251.9) 179.6 (134.7–235.9)
ICR <100 g/g 448 (32.1) 210 (16.6)
ICR >300 g/g 63 (4.5) 106 (8.4)
Adjusted ICR <100 g/day 77 (5.5) 113 (8.9)
Adjusted ICR >300 g/day 203 (14.5) 160 (12.7)
Age, years 50.0 (37.0–62.0) 46.0 (34.0–58.0)
Weight, kg 84.2 (76.0–93.4) 68.1 (60.1–78.6)
Higher education >10 years 265 (19.0) 226 (17.9)
Ingestion of eggs (at least once a week) 1,087 (78.0) 945 (74.7)
Ingestion of fish (at least once a week) 627 (45.0) 530 (41.9)
Ingestion of milk (at least once a week) 637 (45.7) 627 (49.6)
Goiter 416 (33.0) 530 (38.3)
Follow-up
Iodine, g/l 124.0 (78.2–184.0) 93.2 (53.3–58.0)
ICR, g/g 113.9 (82.8–155.1) 149.4 (107.8–205.1)
Adjusted ICR, g/day 181.5 (133.8–244.3) 170.3 (124.9–231.2)
ICR <100 g/g 548 (39.3) 259 (20.5)
ICR >300 g/g 52 (3.7) 112 (8.9)
Adjusted ICR <100 g/day 176 (12.6) 175 (13.8)
Adjusted ICR >300 g/day 198 (14.2) 161 (12.7)
Goiter 493 (39.0) 585 (42.0)
D ata are given as n (%) or medians (IQR).
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Table 2.  Association of categorized ICR at baseline with ICR at follow-up




Model 2: Poisson regression
ICR >100 g/g vs. ICR ≤100 g/g
(follow-up)
RR 
Model 3: Poisson regression





0–100 g/g               –15.67 (–38.58 to 7.24); p = 0.180 0.87 (0.82 to 0.94); p < 0.001 0.82 (0.52 to 1.29); p = 0.389
>100–300 g/g reference reference reference
>300 g/g 74.97 (35.32 to 114.62); p < 0.001 1.06 (0.98 to 1.15); p = 0.130 2.61 (1.79 to 3.82); p < 0.001
Men
ICR (baseline)
0–100 g/g               –25.74 (–51.86 to 0.39); p = 0.053 0.79 (0.71 to 0.87); p < 0.001 0.27 (0.10 to 0.75); p < 0.001
>100–300 g/g reference reference reference
>300 g/g 152.62 (95.81 to 209.44); p < 0.001 1.08 (0.93 to 1.27); p = 0.286 4.66 (2.51 to 8.64); p < 0.001
Women
ICR (baseline)
0–100 g/g 22.88 (–19.09 to 64.86); p = 0.285 1.01 (0.94 to 1.10); p = 0.738 1.39 (0.87 to 2.22); p = 0.174
>100–300 g/g reference reference reference
>300 g/g 23.72 (–32.43 to 79.89); p = 0.407 1.06 (0.98 to 1.15); p = 0.168 2.07 (1.30 to 3.28); p = 0.002
P arentheses contain 95% CI. All models were adjusted for age, weight, sex, education, ingestion of fish, milk and eggs, time between 
baseline and follow-up, and time of urine sampling.
Table 3.  Association of categorized adjusted ICR at baseline with ICR at follow-up




Model 2: Poisson regression
adjusted ICR >100 g/day vs.
adjusted ICR ≤100 g/day
(follow-up)
RR 
Model 3: Poisson regression
adjusted ICR >300 g/g vs.





0–100 g/day                  –25.64 (–74.16 to 22.89); p = 0.300 0.97 (0.91 to 1.03); p = 0.348 1.02 (0.67 to 1.55); p = 0.926
>100–300 g/day reference reference reference
>300 g/day 78.77 (42.45 to 115.08); p < 0.001 1.03 (0.99 to 1.07); p = 0.189 2.20 (1.78 to 2.71); p < 0.001
Men
Adjusted ICR (baseline)
0–100 g/day                  –43.93 (–122.45 to 34.59); p = 0.273 0.94 (0.85 to 1.05); p = 0.297 0.88 (0.44 to 1.75); p = 0.712
>100–300 g/day reference reference reference
>300 g/day 111.36 (60.98 to 161.74); p < 0.001 1.03 (0.98 to 1.08); p = 0.292 2.64 (2.02 to 3.44); p < 0.001
Women
Adjusted ICR (baseline)
0–100 g/day                  –13.08 (–74.05 to 47.89); p = 0.674 0.99 (0.91 to 1.07); p = 0.808 1.09 (0.65 to 1.82); p = 0.757
>100–300 g/day reference reference reference
>300 g/day 37.00 (–15.75 to 89.76); p = 0.169 1.03 (0.96 to 1.09); p = 0.434 1.64 (1.15 to 2.36); p = 0.007
P arentheses contain 95% CI. All models were adjusted for age, weight, sex, education, ingestion of fish, milk and eggs, time between 
baseline and follow-up, and time of urine sampling.
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to a higher UI excretion and consequently to a higher risk 
of goiter. In our analysis, we detected a statistically sig-
nificant association between high adjusted ICR ( 1 300 
  g/day) at baseline and incident goiter in males. These 
results at least partly support the hypothetical UI loss in 
affected individuals.
 Our study indicates that there is a considerable pro-
portion of individuals with a hypothetical iodine loss. In 
SHIP, 4.5% of men and 2.5% of women had an adjusted 
ICR  1 300   g/day at both baseline and follow-up. Should 
further research demonstrate that high UI concentra-
tions are present in a considerable proportion of these 
subjects due to inadequate iodine conservation rather 
than due to high iodine intake, these subjects should con-
sequently be excluded from studies assessing the iodine 
status of populations. Otherwise, such studies would 
overestimate iodine status and the proportion of subjects 
with over-supply.
 In general, ICR predictivity was stronger in males than 
in females. Potentially larger variations in nutritional 
habits in females and genetic as well as metabolic differ-
ences might be responsible for this phenomenon. This 
question cannot be answered by the present study. A lon-
gitudinal study with dietary records and genetic charac-
terization is needed to clarify this point.
 In contrast to some studies  [4, 7, 9] , but in agreement 
with others  [1, 19] , we defined UI by ICR. A couple of 
studies  [8, 28] advised against the use of ICR since it may 
underestimate UI concentrations compared to 24-hour 
urine and overestimate iodine concentrations in women 
compared to men. This problem was tackled using sex- 
and age-adjusted ICR, which was reported to be supe-
rior over UI concentrations and unadjusted ICR  [19] . In 
the present analysis, calculations with adjusted and un-
adjusted ICR revealed similar results. For both defini-
tions, high UI excretion at baseline was significantly as-
sociated with UI excretion at follow-up. The relative risk 
was lower when using adjusted ICR, but confidence lim-
its were smaller compared to analysis with unadjusted 
ICR.
 In SHIP, urine samples were taken in a non-fasting 
state between 07.00 a.m. and 04.00 p.m. The existence of 
a circadian rhythm in UI concentrations is currently un-
der debate. Two studies detected a circadian rhythm in 
UI concentrations  [2, 29] , whereas two others did not  [1, 
28] . In one study  [30] , a significant circadian rhythm of 
ICR was found, with the highest excretion in the late af-
ternoon – 25.8% more than between 7 and 10 a.m. – in-
dicating a dependence of ICR on lunch. Rasmussen et al. 
 [1] suggested avoiding non-fasting samples in the morn-
ing since UI excretion concentrations seemed to be low-
est then. In contrast, Busnardo et al.  [9] reported only 
small variations in UI excretion concentrations in non-
fasting subjects. Taking the time of sampling into ac-
count, the main results of our analyses did not substan-
tially change.
 Assessing UI excretion from 24-hour urine is the most 
reliable method  [31, 32] . However, collection of 24-hour 
urine is difficult and uncomfortable, hence spot urine 
samples normalized to creatinine concentrations are of-
ten used to determine an individual’s UI excretion. It has 
previously been shown that iodine measurements in 24-
hour urine and spot urine samples are comparable  [33, 
34] and yield similar results if age- and sex-specific uri-
nary creatinine excretion is accounted for  [19, 35] .
 One limitation of our study is the characterization of 
nutritional habits. A food frequency questionnaire is not 
the gold standard for determining food intake in this 
context  [24, 36, 37] . It only provides a rough estimate of 
dietary habits, which correspondingly did not allow us 
to examine whether, for example, a sustained higher io-
dized salt intake in a subgroup of males might have con-
tributed to the stronger association. Even though more 
valid dietary records would have been available in the 
present study, we were not able to precisely calculate the 
iodine intake in the individual person. The German io-
dine fortification program is based on a voluntary prin-
ciple, whereby food producers such as canteens, restau-
rants, private bakeries or butchers are not obliged to
extra declare the usage of iodized salt  [38] . Thus, in com-
parison to countries that introduced obligatory iodine 
programs with strict directives on what types of food 
have to be fortified with clearly defined concentrations, 
the iodine content of German food might vary, and the 
consumers are usually not aware of the exact iodine con-
tent.
 Since we only collected information on food intake at 
baseline, it also remains unclear whether participants 
had changed their nutritional habits between baseline 
and follow-up. The weak association between low UI con-
centrations at baseline and follow-up, however, argues 
against the idea that unstable nutritional habits over time 
substantially confounded the association between high 
UI concentrations at baseline and follow-up. Further lim-
itations might have arisen from underreporting medica-
tion. While in SHIP information on drugs is carefully 
collected, we cannot fully exclude recall bias regarding 
iodine medication, which might be particularly present 
for over-the-counter drugs  [39] or repeated administra-
tion of iodine-containing contrast agents.
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 In conclusion, we detected only a weak correlation 
with respect to low ICR. Studies assessing the iodine sta-
tus in a population should take into account that an indi-
vidual with a low UI excretion in one measurement is not 
necessarily permanently iodine deficient. On the other 
hand, current high ICR is predicted by high ICR 5 years 
ago. The mechanisms underlying this relation are cur-
rently not clear. Genetic and non-hereditary determi-
nants of metabolic and renal iodine handling might rep-
resent a hypothetical explanation, but also residual con-
founding cannot unequivocally be ruled out.
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